Suchergebnisse - "van Vollenhoven, Ronald F"

PubPharm (22)

1

A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2017

von Hambardzumyan, K. | Saevarsdottir, S. | Forslind, K. | +5

2

Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis : Results of a Randomized Swedish Trial

enthalten in: Arthritis care & research | 2016

von Eriksson, J. | Wallman, J. | Miller, H. | +5

3

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis : results from the SWEFOT trial

enthalten in: Annals of the rheumatic diseases | 2016

von Kastbom, A. | Forslind, K. | Ernestam, S. | +7

4

Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis : results from the SWEFOT trial

enthalten in: Annals of the rheumatic diseases | 2015

von Saevarsdottir, S. | Rezaei, H. | Geborek, P. | +6

5

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

enthalten in: Arthritis Research & Therapy | 2015

von Nagy, G. | van Vollenhoven, R.

6

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

enthalten in: Arthritis Research & Therapy | 2015

von Nagy, G. | van Vollenhoven, R.

7

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis : 2-year results of the register-enriched randomised controlled SWEFOT trial

enthalten in: Annals of the rheumatic diseases | 2015

von Eriksson, J. | Karlsson, J. | Bratt, J. | +5

8

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA : results from the SWEFOT trial

enthalten in: Annals of the rheumatic diseases | 2015

von Hambardzumyan, K. | Bolce, R. | Saevarsdottir, S. | +7

9

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial

enthalten in: Annals of the rheumatic diseases | 2015

von Eriksson, J. | Karlsson, J. | Bratt, J. | +5

10

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis : 2-year quality-of-life results of the randomised, controlled, SWEFOT trial

enthalten in: Annals of the rheumatic diseases | 2013

von Karlsson, J. | Neovius, M. | Nilsson, J. | +5